Home › NDC Lookup › RxCUI directory › RxCUI 700885

Temozolomide 180 MG Oral Capsule — RxCUI 700885

RxNorm drug concept · Semantic clinical drug
RxCUI 700885 Semantic clinical drug · SCD ● Current RxNorm concept 62 FDA products 144 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI700885
Official nameTemozolomide 180 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped62
Package NDCs mapped144
Reported Medicaid activity (SDUD)4,846 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Temozolomide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Temozolomide is a chemotherapy used to treat aggressive brain tumors — specifically glioblastoma (a fast-growing brain tumor) and anaplastic astrocytoma. It works by getting into c...
  • What exactly is temozolomide treating, and why do I need it?
  • Yes, it does matter. Swallow the capsules whole with a full glass of water — never open, crush, or chew them. Try to avoid taking them right after a high-fat meal, because fat can...
  • How should I take the capsules — does it matter when I take them or whether I eat first?
📖 Read our full Temozolomide guide →

🕸️ Concept Web — How Temozolomide 180 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Temozolomide 180 MG Oral Capsule RxCUI 700885

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Temozolomide 37776
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Temodar 261663
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Temozolomide Oral Capsule 374610
    • Temozolomide Oral Product 1161486
    • Temozolomide Pill 1161487
    • Temozolomide Oral Capsule [Temodar] 366431
    • Temodar Oral Product 1181414
    • Temodar Pill 1181415
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Temozolomide 180 MG SCDC · 700884
  • Temozolomide Oral Capsule SCDF · 374610
  • Temozolomide Oral Product SCDG · 1161486
  • Temozolomide Pill SCDG · 1161487

Brand-Name Concepts

  • Temozolomide 180 MG Oral Capsule [Temodar] SBD · 705619
  • Temozolomide 180 MG [Temodar] SBDC · 705618
  • Temozolomide Oral Capsule [Temodar] SBDF · 366431
  • Temodar Oral Product SBDG · 1181414
  • Temodar Pill SBDG · 1181415
  • Temodar BN · 261663

📦 FDA Products & Package NDCs

62 products · 144 package NDCs
144 package NDCs map to RxCUI 700885 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00085-1366-03 5 PACKET in 1 CARTON (0085-1366-03) / 1 CAPSULE in 1 PACKET... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1366-04 14 PACKET in 1 CARTON (0085-1366-04) / 1 CAPSULE in 1 PACKE... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1381-01 1 VIAL, SINGLE-USE in 1 CARTON (0085-1381-01) / 40 mL in 1... TEMODAR Merck Sharp & Dohme LLC 2009-02-27
00085-1417-02 5 PACKET in 1 CARTON (0085-1417-02) / 1 CAPSULE in 1 PACKET... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1425-03 5 PACKET in 1 CARTON (0085-1425-03) / 1 CAPSULE in 1 PACKET... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1425-04 14 PACKET in 1 CARTON (0085-1425-04) / 1 CAPSULE in 1 PACKE... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1430-03 5 PACKET in 1 CARTON (0085-1430-03) / 1 CAPSULE in 1 PACKET... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1430-04 14 PACKET in 1 CARTON (0085-1430-04) / 1 CAPSULE in 1 PACKE... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1519-03 5 PACKET in 1 CARTON (0085-1519-03) / 1 CAPSULE in 1 PACKET... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-1519-04 14 PACKET in 1 CARTON (0085-1519-04) / 1 CAPSULE in 1 PACKE... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-3004-03 5 PACKET in 1 CARTON (0085-3004-03) / 1 CAPSULE in 1 PACKET... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
00085-3004-04 14 PACKET in 1 CARTON (0085-3004-04) / 1 CAPSULE in 1 PACKE... TEMODAR Merck Sharp & Dohme LLC 1999-08-11
16571-0816-02 20 CAPSULE in 1 BOTTLE (16571-816-02) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0816-41 14 CAPSULE in 1 BOTTLE (16571-816-41) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0816-51 5 CAPSULE in 1 BOTTLE (16571-816-51) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0817-02 20 CAPSULE in 1 BOTTLE (16571-817-02) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0817-41 14 CAPSULE in 1 BOTTLE (16571-817-41) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0817-51 5 CAPSULE in 1 BOTTLE (16571-817-51) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0818-02 20 CAPSULE in 1 BOTTLE (16571-818-02) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0818-41 14 CAPSULE in 1 BOTTLE (16571-818-41) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0818-51 5 CAPSULE in 1 BOTTLE (16571-818-51) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0819-02 20 CAPSULE in 1 BOTTLE (16571-819-02) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0819-41 14 CAPSULE in 1 BOTTLE (16571-819-41) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0819-51 5 CAPSULE in 1 BOTTLE (16571-819-51) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0820-02 20 CAPSULE in 1 BOTTLE (16571-820-02) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0820-41 14 CAPSULE in 1 BOTTLE (16571-820-41) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0820-51 5 CAPSULE in 1 BOTTLE (16571-820-51) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0821-02 20 CAPSULE in 1 BOTTLE (16571-821-02) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16571-0821-51 5 CAPSULE in 1 BOTTLE (16571-821-51) TEMOZOLOMIDE Rising Pharma Holdings, Inc. 2022-10-04
16729-0048-53 1 BOTTLE, GLASS in 1 CARTON (16729-048-53) / 5 CAPSULE in 1... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0048-54 1 BOTTLE, GLASS in 1 CARTON (16729-048-54) / 14 CAPSULE in... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0049-53 1 BOTTLE, GLASS in 1 CARTON (16729-049-53) / 5 CAPSULE in 1... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0049-54 1 BOTTLE, GLASS in 1 CARTON (16729-049-54) / 14 CAPSULE in... Temozolomide Accord Healthcare Inc. 2017-06-13
16729-0050-53 1 BOTTLE, GLASS in 1 CARTON (16729-050-53) / 5 CAPSULE in 1... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0050-54 1 BOTTLE, GLASS in 1 CARTON (16729-050-54) / 14 CAPSULE in... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0051-53 1 BOTTLE, GLASS in 1 CARTON (16729-051-53) / 5 CAPSULE in 1... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0129-53 1 BOTTLE, GLASS in 1 CARTON (16729-129-53) / 5 CAPSULE in 1... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0129-54 1 BOTTLE, GLASS in 1 CARTON (16729-129-54) / 14 CAPSULE in... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0130-53 1 BOTTLE, GLASS in 1 CARTON (16729-130-53) / 5 CAPSULE in 1... Temozolomide Accord Healthcare Inc. 2017-03-07
16729-0130-54 1 BOTTLE, GLASS in 1 CARTON (16729-130-54) / 14 CAPSULE in... Temozolomide Accord Healthcare Inc. 2017-03-07
31722-0411-14 14 CAPSULE in 1 BOTTLE (31722-411-14) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0411-31 5 CAPSULE in 1 BOTTLE (31722-411-31) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0412-14 14 CAPSULE in 1 BOTTLE (31722-412-14) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0412-31 5 CAPSULE in 1 BOTTLE (31722-412-31) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0413-14 14 CAPSULE in 1 BOTTLE (31722-413-14) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0413-31 5 CAPSULE in 1 BOTTLE (31722-413-31) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0414-14 14 CAPSULE in 1 BOTTLE (31722-414-14) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0414-31 5 CAPSULE in 1 BOTTLE (31722-414-31) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0415-14 14 CAPSULE in 1 BOTTLE (31722-415-14) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
31722-0415-31 5 CAPSULE in 1 BOTTLE (31722-415-31) TEMOZOLOMIDE Camber Pharmaceuticals, Inc. 2024-08-23
Observed labelers: Sun Pharmaceutical Industries, Inc. (35) · Rising Pharma Holdings, Inc. (17) · Camber Pharmaceuticals, Inc. (12) · Merck Sharp & Dohme LLC (12) · Accord Healthcare Inc. (11) · Amneal Pharmaceuticals LLC (11) · +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J8700 Temozolomide 33 CMS
J9328 Temozolomide injection 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.